speb/financial-data huggingface dataset:
NHPC.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 1026777100000.00
NHPC.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 773670900000.00
NHPC.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 773670900000.00
NHPC.NS balance_sheet (annual, 2025-03-31) — Total Debt: 415739800000.00
NHPC.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 415739800000.00
NHPC.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 451630600000.00
NHPC.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 451630600000.00
NHPC.NS income_statement (annual, 2025-03-31) — Total Expenses: 59382800000.00
NHPC.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 14568200000.00
NHPC.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 575146500000.00
NHPC.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 575146500000.00
NHPC.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 914162500000.00
NHPC.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 914162500000.00
NHPC.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 473382300000.00
NHPC.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 473382300000.00
NHPC.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: -21401600000.00
NHPC.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 84100000.00
NHPC.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 84100000.00
NHPC.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
NHPC.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
NHPC.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
NHPC.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
NHPC.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 1764000000.00
NHPC.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 1764000000.00
NHPC.NS balance_sheet (annual, 2025-03-31) — Working Capital: 10850400000.00
NHPC.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 10850400000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 15577900000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 32137700000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 10047358491.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.06
NHPC.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2902400000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 4357700000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 4357700000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 10047358491.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.06
NHPC.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 10650200000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — EBIT: 15953500000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — EBITDA: 20311200000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 29235300000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 2608000000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2608000000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -661400000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Net Income: 10650200000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 10650200000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 9474000000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Net Income Extraordinary: 1837600000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 8812600000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 8812600000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 11311600000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -2608000000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2608000000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 20311200000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 8812600000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Operating Income: 13657400000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 32137700000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 2289900000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 6985200000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 13345500000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2902400000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 4357700000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 3871500000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.29
NHPC.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 18480300000.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
NHPC.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
NHPC.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 23398800000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 22207300000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 9960000000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.22
NHPC.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1258600000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 4566100000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 4566100000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 9960000000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.22
NHPC.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2191200000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — EBIT: 280500000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — EBITDA: 4846600000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 20948700000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 3102500000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 3102500000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -1014800000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Net Income: 2191200000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2191200000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -8554800000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Net Income Extraordinary: 11760800000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -9569600000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -9569600000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 3206000000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -3102500000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3102500000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 4846600000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -9569600000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Operating Income: -2450100000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 22207300000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 2721000000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 15368600000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -2822000000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1258600000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 4566100000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 5732800000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
NHPC.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 24657400000.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
NHPC.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
NHPC.NS income_statement (annual, 2026-03-31) — +Operating Expense: 75344900000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 21586500000.00
NHPC.NS income_statement (annual, 2026-03-31) — +Total Revenue: 116152900000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 28155300000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 3870400000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3870400000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 26294000000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 26294000000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 36700000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 36700000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 90152500000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 90152500000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 10070068966.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 1.45
NHPC.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 8789200000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -115722800000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 1927500000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1927500000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 100450300000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 100450300000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 19611500000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 19611500000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 97285900000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 97285900000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -23545100000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -368800000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -18728800000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 1935500000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -650000000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -17840500000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 10822300000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Common Stock: 100450300000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 100450300000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 414371800000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 414371800000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 347438900000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 347438900000.00
NHPC.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 8207400000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1029600000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Current Assets: 146705200000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 146705200000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 169100000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 169100000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Current Debt: 59604200000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 59604200000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 59773300000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 59773300000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 141060100000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 141060100000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 21446400000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 21446400000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Depreciation: 19758500000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 19758500000.00
NHPC.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 19758500000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 6420100000.00
NHPC.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 19758500000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 6420100000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 10070068966.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.45
NHPC.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 37657400000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 14601600000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 176400000.00
NHPC.NS income_statement (annual, 2026-03-31) — EBIT: 43333400000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — EBIT: 8597200000.00
NHPC.NS income_statement (annual, 2026-03-31) — EBITDA: 63091900000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — EBITDA: 15017300000.00
NHPC.NS cash_flow (annual, 2026-03-31) — End Cash Position: 19611500000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 89275800000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -82786600000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -2300000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 2134700000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2134700000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 850196700000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 850196700000.00
NHPC.NS income_statement (annual, 2026-03-31) — Gross Profit: 107945500000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 27125700000.00
NHPC.NS income_statement (annual, 2026-03-31) — Interest Expense: 14230200000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 5742800000.00
NHPC.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 14230200000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 5742800000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -28881100000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 3689100000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Inventory: 2938800000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 2938800000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 935711200000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 935711200000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -111389700000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 44900000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 44900000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 90152500000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 90152500000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 161216600000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 1758400000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1758400000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 461735200000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 461735200000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 463493600000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 463493600000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 150716600000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -34026300000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 244400000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 244400000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 1002700000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 1002700000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 69676700000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 69676700000.00
NHPC.NS income_statement (annual, 2026-03-31) — Minority Interests: -4547200000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -892600000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -50000000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Net Debt: 501727900000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 501727900000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -72300000.00
NHPC.NS income_statement (annual, 2026-03-31) — Net Income: 37657400000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Net Income: 14601600000.00
NHPC.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 37657400000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 14601600000.00
NHPC.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 32371000000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 21086400000.00
NHPC.NS income_statement (annual, 2026-03-31) — Net Income Extraordinary: 9833600000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Net Income Extraordinary: -5592200000.00
NHPC.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 27823800000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 20193800000.00
NHPC.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 27823800000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 20193800000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 29103200000.00
NHPC.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 42204600000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 15494200000.00
NHPC.NS income_statement (annual, 2026-03-31) — Net Interest Income: -14230200000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -5742800000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -2469900000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 127190300000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 116690300000.00
NHPC.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -14230200000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -5742800000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: 14529100000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 2938400000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Net PPE: 850196700000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 850196700000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -115673700000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 10500000000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 412237100000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 412237100000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 83600000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 83600000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 17453900000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 17453900000.00
NHPC.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 63091900000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 15017300000.00
NHPC.NS income_statement (annual, 2026-03-31) — Normalized Income: 27823800000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 20193800000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 32936200000.00
NHPC.NS income_statement (annual, 2026-03-31) — Operating Income: 32600600000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Operating Income: 5539200000.00
NHPC.NS income_statement (annual, 2026-03-31) — Operating Revenue: 116152900000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 28155300000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 10045034805.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 10045034805.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 13985700000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 13985700000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 9513600000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 9513600000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 313921500000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 313921500000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 2134700000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2134700000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 9634900000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 100900800000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 100900800000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 68807000000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 68807000000.00
NHPC.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 10708000000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 3049900000.00
NHPC.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 40603000000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 11146700000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Other Properties: 502757800000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 502757800000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 4828700000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 4828700000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 77674400000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 77674400000.00
NHPC.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Payables: 3870400000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Payables: 3870400000.00
NHPC.NS income_statement (annual, 2026-03-31) — Pretax Income: 29103200000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 2854400000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -50000000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -2469900000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -115722800000.00
NHPC.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 8207400000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1029600000.00
NHPC.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 19758500000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 6420100000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -34026300000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 0.00
NHPC.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 49100000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Share Issued: 10045034805.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 10045034805.00
NHPC.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 10500000000.00
NHPC.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 414371800000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 414371800000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 412237100000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 412237100000.00
NHPC.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
NHPC.NS income_statement (annual, 2026-03-31) — Tax Provision: -3267800000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -18232000000.00
NHPC.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
NHPC.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
NHPC.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 1335400000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 1335400000.00
NHPC.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -8964400000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Total Assets: 1200108900000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 1200108900000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 876107000000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 876107000000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Total Debt: 523266900000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 523266900000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 484048500000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 484048500000.00
NHPC.NS income_statement (annual, 2026-03-31) — Total Expenses: 83552300000.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 22616100000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 716060400000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 716060400000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 1053403700000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1053403700000.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 575000300000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 575000300000.00
NHPC.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
NHPC.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
NHPC.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
NHPC.NS balance_sheet (annual, 2026-03-31) — Working Capital: 5645100000.00
NHPC.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 5645100000.00
NHS income_statement (annual, 2021-10-31) — Basic Average Shares: 17614825.00
NHS income_statement (annual, 2021-10-31) — Basic EPS: 1.52
NHS balance_sheet (annual, 2021-10-31) — Cash Cash Equivalents And Federal Funds Sold: 311809.00
NHS cash_flow (annual, 2021-10-31) — Common Stock Payments: -58768306.00
NHS income_statement (annual, 2021-10-31) — Diluted Average Shares: 17614825.00
NHS income_statement (annual, 2021-10-31) — Diluted EPS: 1.52
NHS cash_flow (annual, 2021-10-31) — Long Term Debt Payments: -10500000.00
NHS cash_flow (annual, 2021-10-31) — Net Preferred Stock Issuance: -19000000.00
NHS cash_flow (annual, 2021-10-31) — Preferred Stock Payments: -19000000.00
NHS cash_flow (annual, 2021-10-31) — Repayment Of Debt: -10500000.00
NHS cash_flow (annual, 2021-10-31) — Repurchase Of Capital Stock: -77768306.00
NHS income_statement (annual, 2022-10-31) — +Operating Expense: 3110667.00
NHS income_statement (annual, 2022-10-31) — +Total Revenue: -30378739.00
NHS balance_sheet (annual, 2022-10-31) — Accounts Payable: 3585830.00
NHS income_statement (annual, 2022-10-31) — Basic Average Shares: 14707130.00
NHS income_statement (annual, 2022-10-31) — Basic EPS: -2.28
NHS cash_flow (annual, 2022-10-31) — Beginning Cash Position: 311809.00
NHS balance_sheet (annual, 2022-10-31) — Capital Stock: 235965256.00
NHS cash_flow (annual, 2022-10-31) — Cash Dividends Paid: -18024943.00
NHS cash_flow (annual, 2022-10-31) — Change In Accrued Expense: -49500.00
NHS cash_flow (annual, 2022-10-31) — Change In Other Current Liabilities: -1154170.00
NHS cash_flow (annual, 2022-10-31) — Change In Payable: -12290845.00
NHS cash_flow (annual, 2022-10-31) — Change In Prepaid Assets: -119521.00
NHS cash_flow (annual, 2022-10-31) — Change In Receivables: -733411.00
NHS cash_flow (annual, 2022-10-31) — Change In Working Capital: -14347447.00
NHS cash_flow (annual, 2022-10-31) — Changes In Cash: -1513406.00
NHS balance_sheet (annual, 2022-10-31) — Common Stock: 235965256.00
NHS cash_flow (annual, 2022-10-31) — Common Stock Dividend Paid: -18024943.00
NHS balance_sheet (annual, 2022-10-31) — Common Stock Equity: 168278813.00
NHS cash_flow (annual, 2022-10-31) — Common Stock Issuance: 38701436.00
NHS balance_sheet (annual, 2022-10-31) — Derivative Product Liabilities: 1201597.00
NHS income_statement (annual, 2022-10-31) — Diluted Average Shares: 14707130.00
NHS income_statement (annual, 2022-10-31) — Diluted EPS: -2.28
NHS income_statement (annual, 2022-10-31) — Diluted NI Availto Com Stockholders: -33489406.00
NHS cash_flow (annual, 2022-10-31) — End Cash Position: -1201597.00
NHS balance_sheet (annual, 2022-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 289013349.00
NHS cash_flow (annual, 2022-10-31) — Financing Cash Flow: 47176493.00
NHS cash_flow (annual, 2022-10-31) — Free Cash Flow: -48689899.00
NHS cash_flow (annual, 2022-10-31) — Gain Loss On Investment Securities: -826806.00
NHS income_statement (annual, 2022-10-31) — Gain On Sale Of Security: -8131089.00
NHS income_statement (annual, 2022-10-31) — General And Administrative Expense: 546598.00
NHS income_statement (annual, 2022-10-31) — Interest Expense: 1017040.00
NHS income_statement (annual, 2022-10-31) — Interest Income: 17620146.00
NHS balance_sheet (annual, 2022-10-31) — Invested Capital: 214171488.00
NHS balance_sheet (annual, 2022-10-31) — Investmentin Financial Assets: 289013349.00
NHS balance_sheet (annual, 2022-10-31) — Investments And Advances: 289013349.00
NHS cash_flow (annual, 2022-10-31) — Issuance Of Capital Stock: 38701436.00
NHS cash_flow (annual, 2022-10-31) — Issuance Of Debt: 26500000.00
NHS balance_sheet (annual, 2022-10-31) — Long Term Debt And Capital Lease Obligation: 45892675.00
NHS cash_flow (annual, 2022-10-31) — Long Term Debt Issuance: 26500000.00
NHS cash_flow (annual, 2022-10-31) — Net Common Stock Issuance: 38701436.00
NHS balance_sheet (annual, 2022-10-31) — Net Debt: 45892675.00
NHS income_statement (annual, 2022-10-31) — Net Income: -33489406.00
NHS income_statement (annual, 2022-10-31) — Net Income Common Stockholders: -33489406.00
NHS income_statement (annual, 2022-10-31) — Net Income Continuous Operations: -33489406.00
NHS income_statement (annual, 2022-10-31) — Net Income From Continuing And Discontinued Operation: -33489406.00
NHS income_statement (annual, 2022-10-31) — Net Income From Continuing Operation Net Minority Interest: -33489406.00
NHS cash_flow (annual, 2022-10-31) — Net Income From Continuing Operations: -33489406.00
NHS income_statement (annual, 2022-10-31) — Net Income Including Noncontrolling Interests: -33489406.00
NHS income_statement (annual, 2022-10-31) — Net Interest Income: 16603106.00
NHS cash_flow (annual, 2022-10-31) — Net Issuance Payments Of Debt: 26500000.00
NHS cash_flow (annual, 2022-10-31) — Net Long Term Debt Issuance: 26500000.00
NHS cash_flow (annual, 2022-10-31) — Net Other Financing Charges: 0.00
NHS balance_sheet (annual, 2022-10-31) — Net Tangible Assets: 168278813.00
NHS income_statement (annual, 2022-10-31) — Normalized Income: -33489406.00
NHS cash_flow (annual, 2022-10-31) — Operating Cash Flow: -48689899.00
NHS income_statement (annual, 2022-10-31) — Operating Revenue: -30378739.00
NHS balance_sheet (annual, 2022-10-31) — Ordinary Shares Number: 19542743.00
NHS cash_flow (annual, 2022-10-31) — Other Non Cash Items: -26240.00
NHS income_statement (annual, 2022-10-31) — Other Operating Expenses: 2564069.00
NHS balance_sheet (annual, 2022-10-31) — Other Payable: 171552.00
NHS balance_sheet (annual, 2022-10-31) — Payables: 3757382.00
NHS balance_sheet (annual, 2022-10-31) — Preferred Securities Outside Stock Equity: 76000000.00
NHS balance_sheet (annual, 2022-10-31) — Preferred Shares Number: 6080000.00
NHS balance_sheet (annual, 2022-10-31) — Prepaid Assets: 138125.00
NHS income_statement (annual, 2022-10-31) — Pretax Income: -33489406.00
NHS balance_sheet (annual, 2022-10-31) — Receivables: 6165225.00
NHS balance_sheet (annual, 2022-10-31) — Retained Earnings: -67686443.00
NHS income_statement (annual, 2022-10-31) — Selling General And Administration: 546598.00
NHS balance_sheet (annual, 2022-10-31) — Share Issued: 19542743.00
NHS balance_sheet (annual, 2022-10-31) — Stockholders Equity: 168278813.00
NHS balance_sheet (annual, 2022-10-31) — Tangible Book Value: 168278813.00
NHS income_statement (annual, 2022-10-31) — Tax Effect Of Unusual Items: 0.00
NHS income_statement (annual, 2022-10-31) — Tax Rate For Calcs: 0.00
NHS balance_sheet (annual, 2022-10-31) — Total Assets: 295316699.00
NHS balance_sheet (annual, 2022-10-31) — Total Capitalization: 214171488.00
NHS balance_sheet (annual, 2022-10-31) — Total Debt: 45892675.00
NHS balance_sheet (annual, 2022-10-31) — Total Equity Gross Minority Interest: 168278813.00
NHS balance_sheet (annual, 2022-10-31) — Total Liabilities Net Minority Interest: 127037886.00
NHS income_statement (annual, 2023-10-31) — +Operating Expense: 6024485.00
NHS income_statement (annual, 2023-10-31) — +Total Revenue: 9742007.00
NHS balance_sheet (annual, 2023-10-31) — Accounts Payable: 2382371.00
NHS balance_sheet (annual, 2023-10-31) — Available For Sale Securities: 1216455.00
NHS income_statement (annual, 2023-10-31) — Basic Average Shares: 23366277.00
NHS income_statement (annual, 2023-10-31) — Basic EPS: 0.16
NHS cash_flow (annual, 2023-10-31) — Beginning Cash Position: -1201597.00
NHS balance_sheet (annual, 2023-10-31) — Capital Stock: 270420476.00
NHS cash_flow (annual, 2023-10-31) — Cash Dividends Paid: -23384118.00
NHS cash_flow (annual, 2023-10-31) — Change In Accrued Expense: 199670.00
NHS cash_flow (annual, 2023-10-31) — Change In Other Current Liabilities: 1468917.00
NHS cash_flow (annual, 2023-10-31) — Change In Payable: -1214905.00
NHS cash_flow (annual, 2023-10-31) — Change In Prepaid Assets: -46895.00
NHS cash_flow (annual, 2023-10-31) — Change In Receivables: -3176862.00
NHS cash_flow (annual, 2023-10-31) — Change In Working Capital: -2770075.00
NHS cash_flow (annual, 2023-10-31) — Changes In Cash: 599042.00
NHS balance_sheet (annual, 2023-10-31) — Common Stock: 270420476.00
NHS cash_flow (annual, 2023-10-31) — Common Stock Dividend Paid: -23384118.00
NHS balance_sheet (annual, 2023-10-31) — Common Stock Equity: 194428506.00
NHS cash_flow (annual, 2023-10-31) — Common Stock Issuance: 45832267.00
NHS income_statement (annual, 2023-10-31) — Diluted Average Shares: 23366277.00
NHS income_statement (annual, 2023-10-31) — Diluted EPS: 0.16
NHS income_statement (annual, 2023-10-31) — Diluted NI Availto Com Stockholders: 3717522.00
NHS cash_flow (annual, 2023-10-31) — End Cash Position: -602555.00
NHS balance_sheet (annual, 2023-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 294593448.00
NHS cash_flow (annual, 2023-10-31) — Financing Cash Flow: 6448149.00
NHS cash_flow (annual, 2023-10-31) — Free Cash Flow: -5849107.00
NHS cash_flow (annual, 2023-10-31) — Gain Loss On Investment Securities: -5377978.00
NHS income_statement (annual, 2023-10-31) — Gain On Sale Of Security: -16365994.00
NHS income_statement (annual, 2023-10-31) — General And Administrative Expense: 701981.00
NHS income_statement (annual, 2023-10-31) — Interest Expense: 3144267.00
NHS income_statement (annual, 2023-10-31) — Interest Income: 22352359.00
NHS balance_sheet (annual, 2023-10-31) — Invested Capital: 260428506.00
NHS balance_sheet (annual, 2023-10-31) — Investmentin Financial Assets: 295809903.00
NHS balance_sheet (annual, 2023-10-31) — Investments And Advances: 295809903.00
NHS cash_flow (annual, 2023-10-31) — Issuance Of Capital Stock: 45832267.00
NHS cash_flow (annual, 2023-10-31) — Issuance Of Debt: 66000000.00
NHS balance_sheet (annual, 2023-10-31) — Long Term Debt And Capital Lease Obligation: 66000000.00
NHS cash_flow (annual, 2023-10-31) — Long Term Debt Issuance: 66000000.00
NHS cash_flow (annual, 2023-10-31) — Long Term Debt Payments: -46000000.00
NHS cash_flow (annual, 2023-10-31) — Net Common Stock Issuance: 45832267.00
NHS balance_sheet (annual, 2023-10-31) — Net Debt: 66000000.00
NHS income_statement (annual, 2023-10-31) — Net Income: 3717522.00
NHS income_statement (annual, 2023-10-31) — Net Income Common Stockholders: 3717522.00
NHS income_statement (annual, 2023-10-31) — Net Income Continuous Operations: 3717522.00
NHS income_statement (annual, 2023-10-31) — Net Income From Continuing And Discontinued Operation: 3717522.00
NHS income_statement (annual, 2023-10-31) — Net Income From Continuing Operation Net Minority Interest: 3717522.00
NHS cash_flow (annual, 2023-10-31) — Net Income From Continuing Operations: 3717522.00
NHS income_statement (annual, 2023-10-31) — Net Income Including Noncontrolling Interests: 3717522.00
NHS income_statement (annual, 2023-10-31) — Net Interest Income: 19208092.00
NHS cash_flow (annual, 2023-10-31) — Net Issuance Payments Of Debt: 20000000.00
NHS cash_flow (annual, 2023-10-31) — Net Long Term Debt Issuance: 20000000.00
NHS cash_flow (annual, 2023-10-31) — Net Other Financing Charges: 0.00
NHS cash_flow (annual, 2023-10-31) — Net Preferred Stock Issuance: -36000000.00
NHS balance_sheet (annual, 2023-10-31) — Net Tangible Assets: 194428506.00
NHS income_statement (annual, 2023-10-31) — Normalized Income: 3717522.00
NHS cash_flow (annual, 2023-10-31) — Operating Cash Flow: -5849107.00
NHS income_statement (annual, 2023-10-31) — Operating Revenue: 9742007.00
NHS balance_sheet (annual, 2023-10-31) — Ordinary Shares Number: 26075951.00
NHS cash_flow (annual, 2023-10-31) — Other Non Cash Items: -1418576.00
NHS income_statement (annual, 2023-10-31) — Other Operating Expenses: 5322504.00
NHS balance_sheet (annual, 2023-10-31) — Other Payable: 778639.00
NHS balance_sheet (annual, 2023-10-31) — Payables: 3161010.00
NHS balance_sheet (annual, 2023-10-31) — Preferred Securities Outside Stock Equity: 39932108.00
NHS cash_flow (annual, 2023-10-31) — Preferred Stock Payments: -36000000.00
NHS balance_sheet (annual, 2023-10-31) — Prepaid Assets: 163053.00
NHS income_statement (annual, 2023-10-31) — Pretax Income: 3717522.00
NHS balance_sheet (annual, 2023-10-31) — Receivables: 7912603.00
NHS cash_flow (annual, 2023-10-31) — Repayment Of Debt: -46000000.00
NHS cash_flow (annual, 2023-10-31) — Repurchase Of Capital Stock: -36000000.00
NHS balance_sheet (annual, 2023-10-31) — Retained Earnings: -75991970.00
NHS income_statement (annual, 2023-10-31) — Selling General And Administration: 701981.00
NHS balance_sheet (annual, 2023-10-31) — Share Issued: 26075951.00
NHS balance_sheet (annual, 2023-10-31) — Stockholders Equity: 194428506.00
NHS balance_sheet (annual, 2023-10-31) — Tangible Book Value: 194428506.00
NHS income_statement (annual, 2023-10-31) — Tax Effect Of Unusual Items: 0.00
NHS income_statement (annual, 2023-10-31) — Tax Rate For Calcs: 0.21
NHS balance_sheet (annual, 2023-10-31) — Total Assets: 303907526.00
NHS balance_sheet (annual, 2023-10-31) — Total Capitalization: 260428506.00
NHS balance_sheet (annual, 2023-10-31) — Total Debt: 66000000.00
NHS balance_sheet (annual, 2023-10-31) — Total Equity Gross Minority Interest: 194428506.00
NHS balance_sheet (annual, 2023-10-31) — Total Liabilities Net Minority Interest: 109479020.00
NHS income_statement (annual, 2024-10-31) — +Operating Expense: 3807844.00
NHS income_statement (annual, 2024-10-31) — +Total Revenue: 41747733.00
NHS balance_sheet (annual, 2024-10-31) — Accounts Payable: 5364247.00
NHS balance_sheet (quarterly, 2024-10-31) — Accounts Payable: 5364247.00
NHS balance_sheet (annual, 2024-10-31) — Available For Sale Securities: 8334057.00
NHS balance_sheet (quarterly, 2024-10-31) — Available For Sale Securities: 8334057.00
NHS income_statement (annual, 2024-10-31) — Basic Average Shares: 26496562.00
NHS income_statement (annual, 2024-10-31) — Basic EPS: 1.43
NHS cash_flow (annual, 2024-10-31) — Beginning Cash Position: -602555.00
NHS balance_sheet (annual, 2024-10-31) — Capital Stock: 286061504.00
NHS balance_sheet (quarterly, 2024-10-31) — Capital Stock: 286061504.00
NHS cash_flow (annual, 2024-10-31) — Cash Dividends Paid: -28782983.00
NHS cash_flow (annual, 2024-10-31) — Change In Accrued Expense: -174707.00
NHS cash_flow (annual, 2024-10-31) — Change In Other Current Liabilities: 23376.00
NHS cash_flow (annual, 2024-10-31) — Change In Payable: 2985221.00
NHS cash_flow (annual, 2024-10-31) — Change In Prepaid Assets: 34249.00
NHS cash_flow (annual, 2024-10-31) — Change In Receivables: 2147162.00
NHS cash_flow (annual, 2024-10-31) — Change In Working Capital: 5015301.00
NHS cash_flow (annual, 2024-10-31) — Changes In Cash: 379426.00
NHS balance_sheet (annual, 2024-10-31) — Common Stock: 286061504.00
NHS balance_sheet (quarterly, 2024-10-31) — Common Stock: 286061504.00
NHS cash_flow (annual, 2024-10-31) — Common Stock Dividend Paid: -28782983.00
NHS balance_sheet (annual, 2024-10-31) — Common Stock Equity: 234140262.00
NHS balance_sheet (quarterly, 2024-10-31) — Common Stock Equity: 234140262.00
NHS cash_flow (annual, 2024-10-31) — Common Stock Issuance: 30557448.00
NHS income_statement (annual, 2024-10-31) — Diluted Average Shares: 26496562.00
NHS income_statement (annual, 2024-10-31) — Diluted EPS: 1.43
NHS income_statement (annual, 2024-10-31) — Diluted NI Availto Com Stockholders: 37939889.00
NHS cash_flow (annual, 2024-10-31) — End Cash Position: -223129.00
NHS balance_sheet (annual, 2024-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 309326074.00
NHS balance_sheet (quarterly, 2024-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 309326074.00
NHS cash_flow (annual, 2024-10-31) — Financing Cash Flow: -20725535.00
NHS cash_flow (annual, 2024-10-31) — Free Cash Flow: 21104961.00
NHS cash_flow (annual, 2024-10-31) — Gain Loss On Investment Securities: -19970471.00
NHS income_statement (annual, 2024-10-31) — Gain On Sale Of Security: -3460078.00
NHS income_statement (annual, 2024-10-31) — General And Administrative Expense: 949925.00
NHS income_statement (annual, 2024-10-31) — Interest Expense: 3190252.00
NHS income_statement (annual, 2024-10-31) — Interest Income: 22802068.00
NHS balance_sheet (annual, 2024-10-31) — Invested Capital: 277640262.00
NHS balance_sheet (quarterly, 2024-10-31) — Invested Capital: 277640262.00
NHS balance_sheet (annual, 2024-10-31) — Investmentin Financial Assets: 317660131.00
NHS balance_sheet (quarterly, 2024-10-31) — Investmentin Financial Assets: 317660131.00
NHS balance_sheet (annual, 2024-10-31) — Investments And Advances: 317660131.00
NHS balance_sheet (quarterly, 2024-10-31) — Investments And Advances: 317660131.00
NHS cash_flow (annual, 2024-10-31) — Issuance Of Capital Stock: 30557448.00
NHS cash_flow (annual, 2024-10-31) — Issuance Of Debt: 28000000.00
NHS balance_sheet (annual, 2024-10-31) — Long Term Debt And Capital Lease Obligation: 43500000.00
NHS balance_sheet (quarterly, 2024-10-31) — Long Term Debt And Capital Lease Obligation: 43500000.00
NHS cash_flow (annual, 2024-10-31) — Long Term Debt Issuance: 28000000.00
NHS cash_flow (annual, 2024-10-31) — Long Term Debt Payments: -50500000.00
NHS cash_flow (annual, 2024-10-31) — Net Common Stock Issuance: 30557448.00
NHS balance_sheet (annual, 2024-10-31) — Net Debt: 43500000.00
NHS balance_sheet (quarterly, 2024-10-31) — Net Debt: 43500000.00
NHS income_statement (annual, 2024-10-31) — Net Income: 37939889.00
NHS income_statement (annual, 2024-10-31) — Net Income Common Stockholders: 37939889.00
NHS income_statement (annual, 2024-10-31) — Net Income Continuous Operations: 37939889.00
NHS income_statement (annual, 2024-10-31) — Net Income From Continuing And Discontinued Operation: 37939889.00
NHS income_statement (annual, 2024-10-31) — Net Income From Continuing Operation Net Minority Interest: 37939889.00
NHS cash_flow (annual, 2024-10-31) — Net Income From Continuing Operations: 37939889.00
NHS income_statement (annual, 2024-10-31) — Net Income Including Noncontrolling Interests: 37939889.00
NHS income_statement (annual, 2024-10-31) — Net Interest Income: 19611816.00
NHS cash_flow (annual, 2024-10-31) — Net Issuance Payments Of Debt: -22500000.00
NHS cash_flow (annual, 2024-10-31) — Net Long Term Debt Issuance: -22500000.00
NHS cash_flow (annual, 2024-10-31) — Net Other Financing Charges: 0.00
NHS balance_sheet (annual, 2024-10-31) — Net Tangible Assets: 234140262.00
NHS balance_sheet (quarterly, 2024-10-31) — Net Tangible Assets: 234140262.00
NHS income_statement (annual, 2024-10-31) — Normalized Income: 37939889.00
NHS cash_flow (annual, 2024-10-31) — Operating Cash Flow: 21104961.00
NHS income_statement (annual, 2024-10-31) — Operating Revenue: 41747733.00
NHS balance_sheet (annual, 2024-10-31) — Ordinary Shares Number: 29916986.00
NHS balance_sheet (quarterly, 2024-10-31) — Ordinary Shares Number: 29916986.00
NHS cash_flow (annual, 2024-10-31) — Other Non Cash Items: -1879758.00
NHS income_statement (annual, 2024-10-31) — Other Operating Expenses: 2857919.00